Diffuse Midline Glioma: Clinical Trials

4 trials for Diffuse Midline Glioma, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 suspended, 1 recruiting, 1 terminated. 4 Phase 2, 1 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 24Suspended 2, Recruiting 1, Terminated 1
Phase 11Suspended 1

Follow Diffuse Midline Glioma: new trials by email Literature Review of Diffuse Midline Glioma trials Research Report on Diffuse Midline Glioma

Trials (filtered) newest first · largest first

All 4 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
PEP-CMV + Nivolumab for Newly Diagnosed Diffuse Midline Glioma/High-grade Glioma and Recurrent Diffuse Midline Glioma/High-grade Glioma, Medulloblastoma, and Ependymoma
PEP-CMV vaccine, Tetanus booster, Nivolumab - Diffuse Midline Glioma, Diffuse Midline High-grade Glioma
Phase 1 / Phase 2SuspendedWashington University School of Medicine682026-11-302026-10-30
Illuminate: A Clinical Study Evaluating CAR T Immune Cell Therapy (BCB-276) for Patients With Diffuse Intrinsic Pontine Glioma (DIPG).
BCB-276 - Diffuse Intrinsic Pontine Glioma, DIPG
Phase 2RecruitingBrainChild Bio, Inc752026-09-042026-10-28
A Phase 2 Study of Sonodynamic Therapy Using SONALA-001 and Exablate 4000 Type 2.0 in Patients with DIPG
SONALA-001 (ALA) and MR-Guided Focused Ultrasound device (MRgFUS) - Diffuse Intrinsic Pontine Glioma, Diffuse Midline Glioma
Phase 2SuspendedSonALAsense, Inc.152022-08-122024-09-19
Oral ONC201 in Adult Recurrent Glioblastoma
Dordaviprone (ONC201) - Glioblastoma, Diffuse Midline Glioma
Phase 2TerminatedJazz Pharmaceuticals842016-01-012024-12-24

Narrower conditions

Diffuse Intrinsic Pontine Glioma (3)  ·  Brain Neoplasms (1)  ·  Central Nervous System Neoplasms (1)  ·  Ependymoma (1)  ·  Glioblastoma (1)  ·  Medulloblastoma (1)  ·  Neoplasms (1)  ·  Recurrence (1)

Broader conditions

Glioma (4)  ·  Neoplasms by Histologic Type (4)  ·  Neoplasms, Germ Cell and Embryonal (4)  ·  Neoplasms, Glandular and Epithelial (4)  ·  Neoplasms, Nerve Tissue (4)  ·  Neoplasms, Neuroepithelial (4)  ·  Neuroectodermal Tumors (4)  ·  Brain Diseases (3)  ·  Brain Stem Neoplasms (3)  ·  Central Nervous System Diseases (3)  ·  Infratentorial Neoplasms (3)  ·  Neoplasms (3)  ·  Neoplasms by Site (3)  ·  Nervous System Diseases (3)  ·  Nervous System Neoplasms (3)

Interventions

Nivolumab (1)  ·  TIC10 compound (1)  ·  Temozolomide (1)

Sponsors

BrainChild Bio, Inc (1)  ·  Jazz Pharmaceuticals (1)  ·  SonALAsense, Inc. (1)  ·  Washington University School of Medicine (1)

Countries

United States (4)

Top investigators

Cori Abikoff, MD (1)  ·  Corina Andresen, MD (1)  ·  Eric M Thompson, M.D. (1)

Results publications

PMID 31456142, PMID 34003586, PMID 38335473

NIH funding

R01CA296813 (1), R44CA261516 (1)